Top

Published in:

01-07-2019 | Prostate Cancer | Editorial

From indecision to precision: advances in imaging in metastatic prostate cancer

Authors: D. Bolton, M. Frydenberg

Published in: World Journal of Urology | Issue 7/2019

Excerpt

There can be little doubt that advances in medical imaging have had the greatest influence on prostate cancer management, since the identification of PSA and its use as the dominant serum biomarker for prostate cancer. Currently available imaging formats using MRI and PET technology have become incorporated into the treatment algorithm for prostate cancer in a manner that could not have been conceived in the early phase of this current era of prostate cancer treatment. …

Marenco J, Orczyk C, Collins T, Moore C, Emberton M (2019) Role of MRI in planning radical prostatectomy: what is the added value? World J Urol. https://doi.org/10.1007/s00345-019-02762-2 CrossRefPubMed

Pokorny M, Kua B, Esler R, Yaxley J, Samaratunga H, Dunglison N, Gianduzzo T, Coughlin G, Holt R, Laing B, Ault D, Brown N, Parkinson R, Thompson L (2018) MRI-guided in-bore biopsy for prostate cancer: what does the evidence say? A case series of 554 patients and a review of the current literature. World J Urol. https://doi.org/10.1007/s00345-018-2497-y CrossRefPubMed

Duncan C, Joon DL, Lawrentschuk N, Jenkins T, Schneider M, Khoo V, Chao M, Lawlor M, O’Meara R, Berry C, Viotto A, Brown K, Wada M, Foroudi F, Sengupta S (2018) Fiducial markers: can the urologist do better? World J Urol. https://doi.org/10.1007/s00345-018-2515-0 CrossRefPubMed

Sathianathen NJ, Butaney M, Konety BR (2018) The utility of PET-based imaging for prostate cancer biochemical recurrence: a systematic review and meta-analysis. World J Urol. https://doi.org/10.1007/s00345-018-2403-7 CrossRefPubMed

Fankhauser CD, Poyet C, Kroeze SGC, Kranzbühler B, Schüler HIG, Guckenberger M, Kaufmann PA, Hermanns T, Burger IA (2019) Current and potential future role of PSMA-PET in patients with castration-resistant prostate cancer. World J Urol 37(3):457–467. https://doi.org/10.1007/s00345-018-2408-2 CrossRefPubMed

Eapen RS, Nzenza TC, Murphy DG, Hofman M, Cooperberg M, Lawrentschuk N (2018) PSMA PET applications in the prostate cancer journey: from diagnosis to theranostics. World J Urol. https://doi.org/10.1007/s00345-018-2524-z CrossRefPubMed

Title: From indecision to precision: advances in imaging in metastatic prostate cancer
Authors: D. Bolton
M. Frydenberg
Publication date: 01-07-2019
Publisher: Springer Berlin Heidelberg
Keywords: Prostate Cancer
Prostate Cancer
Published in: World Journal of Urology / Issue 7/2019
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-019-02820-9

At a glance: The STEP trials

Springer Medicine

From indecision to precision: advances in imaging in metastatic prostate cancer

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 7/2019

A comprehensive analysis of cost of an active surveillance cohort compared to radical prostatectomy as primary treatment for prostate cancer

Does routine repeat imaging change management in high-grade renal trauma? Results from three level 1 trauma centers

Supracostal access tubeless percutaneous nephrolithotomy: minimizing complications

Can contrast-enhanced ultrasound and acoustic radiation force impulse imaging characterize CT-indeterminate renal masses? A prospective evaluation with histological confirmation

Fiducial markers: can the urologist do better?

Electroacupuncture for postmenopausal women with stress urinary incontinence: secondary analysis of a randomized controlled trial